The company is preparing for extensive clinical studies during the 2023 cold-and-flu season CLEVELAND, June 28, 2023 /PRNewswire/ — IdentifySensors® Biologics, a leading developer of digital diagnostic technologies, announces the formation of the company’s new Clinical Studies Group,…
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.